[1]
"Retrospective Comparison of Efficacy and Safety of Basiliximab and Antithymocyte Globulin in Kidney Transplant Recipients", KJPS, م 1, عدد 1, أغسطس 2021, doi: 10.53332/kjps.v1i1.40.